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Background
Little is known about the prices and availability of medi-
cines for chronic diseases used by older people in the Asia
Pacific Region. The objective of this study was to assess
the availability and prices of essential medicines for
chronic diseases in 11 countries, namely China, Fiji, India,
Indonesia, Lao, Malaysia, Mongolia, the Philippines, Sri
Lanka, Thailand and Vietnam. The study was carried out
at an international level.
Methods
A secondary analysis of medicine prices and availability
data from the Health Action International’s database on
medicine prices, availability and affordability was underta-
ken in March - May 2015. Data on the availability and
price of 15 medicines used for chronic diseases prevalent
in the older population were obtained from facility-based
surveys conducted in 11 countries between 2001 and
2013. Prices were converted into the base year of 2014.
Patient prices were adjusted for inflation and purchasing
power parity and procurement prices for inflation and offi-
cial exchange rates. Data were analysed for lowest priced
generic (LPG) and innovator brand (IB) products in both
the public and private sectors.
Results
The availability of medicines for chronic diseases was
suboptimal across countries in the Region. The median
availability of any medicine (IB or LPG) in the public
sector was 35.5% compared with 56.7% in the private
sector. Thailand and Indonesia had the highest levels of
availability in the public sector (80% and 60.1% respec-
tively) while in the private sector it was India and Fiji (90%
and 83.4% respectively).
Countries in the Region paid 1.4 times the international
reference price (IRP) to procure LPGs and 9.1 times the
price for IBs. India and Fiji achieved low procurement
prices (0.4 and 0.6 times IRP for LPGs) while the Philip-
pines had the highest procurement prices for both IBs and
LPGs. In general, patient prices were lower in the public
sector than in the private sector (21.5 times IRP vs.
32.2 times for IBs and 6.6 times vs. 11.5 times for LPGs).
In the public sector, Malaysia and India provided medi-
cines free of charge while the Philippines charged the
highest price.
Conclusions
The availability and prices of medicines for chronic con-
ditions were highly variable across the Asia Pacific
Region. Medicines were more available in the private
sector, but at an excessive price. Implementation of poli-
cies to improve the availability and reduce the prices of
essential medicines for chronic diseases is needed.
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